Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users

Background: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. Objectives: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. Methods: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. Results: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. Conclusions: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels.

Saved in:
Bibliographic Details
Main Authors: Allard, Neeltje A.E., Janssen, Lando, Lagerwaard, Bart, Nuijten, Malou A.H., Bongers, Coen C.W.G., Rodenburg, Richard J., Thompson, Paul D., Eijsvogels, Thijs M.H., Assendelft, Willem J.J., Schirris, Tom J.J., Timmers, Silvie, Hopman, Maria T.E.
Format: Article/Letter to editor biblioteca
Language:English
Subjects:coenzyme Q10, moderate-intensity exercise, muscle injury, muscle performance, statin-associated muscle symptoms,
Online Access:https://research.wur.nl/en/publications/prolonged-moderate-intensity-exercise-does-not-increase-muscle-in
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-613274
record_format koha
spelling dig-wur-nl-wurpubs-6132742024-12-04 Allard, Neeltje A.E. Janssen, Lando Lagerwaard, Bart Nuijten, Malou A.H. Bongers, Coen C.W.G. Rodenburg, Richard J. Thompson, Paul D. Eijsvogels, Thijs M.H. Assendelft, Willem J.J. Schirris, Tom J.J. Timmers, Silvie Hopman, Maria T.E. Article/Letter to editor Journal of the American College of Cardiology 81 (2023) 14 ISSN: 0735-1097 Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users 2023 Background: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. Objectives: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. Methods: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. Results: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. Conclusions: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels. en application/pdf https://research.wur.nl/en/publications/prolonged-moderate-intensity-exercise-does-not-increase-muscle-in 10.1016/j.jacc.2023.01.043 https://edepot.wur.nl/628734 coenzyme Q10 moderate-intensity exercise muscle injury muscle performance statin-associated muscle symptoms Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic coenzyme Q10
moderate-intensity exercise
muscle injury
muscle performance
statin-associated muscle symptoms
coenzyme Q10
moderate-intensity exercise
muscle injury
muscle performance
statin-associated muscle symptoms
spellingShingle coenzyme Q10
moderate-intensity exercise
muscle injury
muscle performance
statin-associated muscle symptoms
coenzyme Q10
moderate-intensity exercise
muscle injury
muscle performance
statin-associated muscle symptoms
Allard, Neeltje A.E.
Janssen, Lando
Lagerwaard, Bart
Nuijten, Malou A.H.
Bongers, Coen C.W.G.
Rodenburg, Richard J.
Thompson, Paul D.
Eijsvogels, Thijs M.H.
Assendelft, Willem J.J.
Schirris, Tom J.J.
Timmers, Silvie
Hopman, Maria T.E.
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
description Background: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. Objectives: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. Methods: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. Results: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. Conclusions: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels.
format Article/Letter to editor
topic_facet coenzyme Q10
moderate-intensity exercise
muscle injury
muscle performance
statin-associated muscle symptoms
author Allard, Neeltje A.E.
Janssen, Lando
Lagerwaard, Bart
Nuijten, Malou A.H.
Bongers, Coen C.W.G.
Rodenburg, Richard J.
Thompson, Paul D.
Eijsvogels, Thijs M.H.
Assendelft, Willem J.J.
Schirris, Tom J.J.
Timmers, Silvie
Hopman, Maria T.E.
author_facet Allard, Neeltje A.E.
Janssen, Lando
Lagerwaard, Bart
Nuijten, Malou A.H.
Bongers, Coen C.W.G.
Rodenburg, Richard J.
Thompson, Paul D.
Eijsvogels, Thijs M.H.
Assendelft, Willem J.J.
Schirris, Tom J.J.
Timmers, Silvie
Hopman, Maria T.E.
author_sort Allard, Neeltje A.E.
title Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
title_short Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
title_full Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
title_fullStr Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
title_full_unstemmed Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
title_sort prolonged moderate-intensity exercise does not increase muscle injury markers in symptomatic or asymptomatic statin users
url https://research.wur.nl/en/publications/prolonged-moderate-intensity-exercise-does-not-increase-muscle-in
work_keys_str_mv AT allardneeltjeae prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT janssenlando prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT lagerwaardbart prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT nuijtenmalouah prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT bongerscoencwg prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT rodenburgrichardj prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT thompsonpauld prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT eijsvogelsthijsmh prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT assendelftwillemjj prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT schirristomjj prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT timmerssilvie prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
AT hopmanmariate prolongedmoderateintensityexercisedoesnotincreasemuscleinjurymarkersinsymptomaticorasymptomaticstatinusers
_version_ 1819141718254026752